These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30717741)

  • 1. Does the economic recession influence the incidence of pertussis in a cosmopolitan European city?
    Brugueras S; Rius C; Millet JP; Casals M; Caylà JA;
    BMC Public Health; 2019 Feb; 19(1):144. PubMed ID: 30717741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of acellular pertussis vaccine and evolution of pertussis incidence in the community of Madrid from 1998 to 2015.
    Latasa P; García-Comas L; Gil de Miguel A; Barranco MD; Rodero I; Sanz JC; Ordobás M; Arce A; Garrido-Estepa M
    Vaccine; 2018 Mar; 36(12):1643-1649. PubMed ID: 29439872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of pertussis in two Ibero-American countries with different vaccination policies: lessons derived from different surveillance systems.
    Solano R; Masa-Calles J; Garib Z; Grullón P; Santiago SL; Brache A; Domínguez Á; Caylà JA
    BMC Public Health; 2016 Nov; 16(1):1178. PubMed ID: 27876021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine.
    Sala-Farré MR; Arias-Varela C; Recasens-Recasens A; Simó-Sanahuja M; Muñoz-Almagro C; Pérez-Jové J
    Enferm Infecc Microbiol Clin; 2015 Jan; 33(1):27-31. PubMed ID: 24216286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of São Paulo, Brazil.
    Fernandes EG; Sartori AMC; de Soárez PC; Carvalhanas TRMP; Rodrigues M; Novaes HMD
    BMC Infect Dis; 2018 Mar; 18(1):126. PubMed ID: 29534683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1-9 years old in Catalonia and Navarra (Spain).
    Plans P; Toledo D; Sala MR; Camps N; Villanova M; Rodríguez R; Alvarez J; Solano R; García-Cenoz M; Barrabeig I; Godoy P; Minguell S
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):2059-2067. PubMed ID: 27612470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis outbreak investigation of Mekdela district, South Wollo zone, Amhara region, North-West Ethiopia.
    Alamaw SD; Kassa AW; Gelaw YA
    BMC Res Notes; 2017 Aug; 10(1):420. PubMed ID: 28830538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of pertussis cases in the Vallès region, Catalonia, Spain, September 2023 to April 2024.
    Poltorak V; Cabré-Riera A; Martínez-Botías F; Borràs López E; Clotet Romero L; Sala Farré MR; Jané Checa M;
    Euro Surveill; 2024 Jun; 29(24):. PubMed ID: 38873794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
    Witt MA; Katz PH; Witt DJ
    Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis in Poland in 2011.
    Paradowska-Stankiewicz I; Rudowska J
    Przegl Epidemiol; 2013; 67(2):199-201, 319-21. PubMed ID: 24040716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of pertussis vaccination and duration of immunity.
    Schwartz KL; Kwong JC; Deeks SL; Campitelli MA; Jamieson FB; Marchand-Austin A; Stukel TA; Rosella L; Daneman N; Bolotin S; Drews SJ; Rilkoff H; Crowcroft NS
    CMAJ; 2016 Nov; 188(16):E399-E406. PubMed ID: 27672225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
    Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immunisation strategies for pertussis vaccines in Jinan, China - an interrupted time-series study.
    Liu TC; Zhang J; Liu SQ; Yin AT; Ruan SM
    Epidemiol Infect; 2020 Feb; 148():e26. PubMed ID: 32046804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.
    Gill CJ; Mwananyanda L; MacLeod W; Kwenda G; Mwale M; Williams AL; Siazeele K; Yang Z; Mwansa J; Thea DM
    Clin Infect Dis; 2016 Dec; 63(suppl 4):S154-S164. PubMed ID: 27838668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resurgence of pertussis in Europe.
    Celentano LP; Massari M; Paramatti D; Salmaso S; Tozzi AE;
    Pediatr Infect Dis J; 2005 Sep; 24(9):761-5. PubMed ID: 16148840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of pertussis outbreaks in Catalonia, Spain, 1997 to 2010.
    Crespo I; Broner S; Soldevila N; Martínez A; Godoy P; Sala-Farré MR; Company M; Rius C; Domínguez A; Group Of Catalonia TP
    Hum Vaccin Immunother; 2015; 11(1):231-5. PubMed ID: 25483541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.